Revenue | $10 - $100 million See Exact Annual Revenue |
---|---|
Employees | 10 - 100Exact Company Size |
Primary Industry | 3254 Pharmaceutical & Medicine Manufacturing |
Address | 130 Turner St Bldg 3 Ste 200 Waltham, MA 02453 alcresta.com |
Alcresta Therapeutics | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Date | Investors | Percent Raised | Target Size |
---|---|---|---|
March 3, 2020 | 17 | 50% | $20 MM |
Complete list of funding rounds and total amounts in the Company Report |
$ Millions (Industry Average) | |
---|---|
Alcresta Therapeutics Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
ALCRESTA PHARMACEUTICALS Medical nutritional formula, namely, formula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and would healing, mental illness, pulmonary, muscular and respiratory diseases and disorders | 07/20/2015 |
FULFILLING POTENTIAL Medical nutritional formula, namely, formula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and would healing, mental illness, pulmonary, muscular and respiratory diseases and disorders | 07/20/2015 |
Publisher: AnythingResearch
Company | Headquarters | Revenue ($ MM) |
---|---|---|
PFIZER | New York, NY | 100 |
ABBOTT LABORATORIES | Abbott Park, IL | 91 |
BRISTOL-MYERS SQUIBB | Princeton, NJ | 86 |
MERCK SHARP & DOHME | Rahway, NJ | 66 |
ELI LILLY | Indianapolis, IN | 65 |
CSL BEHRING | King Of Prussia, PA | 64 |
CSLB HOLDINGS | King Of Prussia, PA | 63 |
MERCK | Rahway, NJ | 62 |
ALLERGAN | Chicago, IL | 61 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
REPLIGEN | Waltham, MA | 100 |
APELLIS PHARMACEUTICALS | Waltham, MA | 67 |
CUBIST PHARMACEUTICALS | Lexington, MA | 59 |
BIOVERATIV U.S. LLC. | Waltham, MA | 58 |
ABCAM | Waltham, MA | 29 |
KARYOPHARM THERAPEUTICS | Newton, MA | 25 |
Company | Revenue ($ MM) |
---|---|
|